An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children.
about
HUS and TTP in ChildrenHemolytic uremic syndrome: toxins, vessels, and inflammationHaemolytic uraemic syndrome.Renal and neurological involvement in typical Shiga toxin-associated HUS.Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed.Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.[Treatment of typical hemolytic-uremic syndrome. Knowledge gained from analyses of the 2011 E. coli outbreak].Risk factors for development of hemolytic uremic syndrome in a cohort of adult patients with STEC 0104:H4 infection.Brain magnetic resonance imaging pattern and outcome in children with haemolytic-uraemic syndrome and neurological impairment treated with eculizumab.Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome.Shiga toxin-producing Escherichia coli O157 is more likely to lead to hospitalization and death than non-O157 serogroups--except O104Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complementNeurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome.L-arginine/NO pathway is altered in children with haemolytic-uraemic syndrome (HUS).Upregulation of Shiga toxin receptor CD77/Gb3 and interleukin-1β expression in the brain of EHEC patients with hemolytic uremic syndrome and neurologic symptoms.Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults.Gram-negative organisms in peritoneal dialysis peritonitis: an early indication for surgery in patients with haemolytic uraemic syndrome?Cerebral Hemodynamics in Patients with Hemolytic Uremic Syndrome Assessed by Susceptibility Weighted Imaging and Four-Dimensional Non-Contrast MR AngiographyHemolytic uremic syndrome in adults: A case reportShiga toxin-producing Escherichia coli: a single-center, 11-year pediatric experience.Molecular characterization and antibiotic resistance of enterotoxigenic and entero-aggregative Escherichia coli isolated from raw milk and unpasteurized cheeses.Lessons Learned From Outbreaks of Shiga Toxin Producing Escherichia coliApheresis therapy in children: an overview of key technical aspects and a review of experience in pediatric renal disease.An emerging molecular understanding and novel targeted treatment approaches in pediatric kidney diseases.Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4.Systemic complement activation and complement gene analysis in enterohaemorrhagic Escherichia coli-associated paediatric haemolytic uraemic syndrome.Early Terminal Complement Blockade and C6 Deficiency Are Protective in Enterohemorrhagic Escherichia coli-Infected Mice.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Evidence of non-O157 Shiga toxin-producing Escherichia coli in the feces of meat goats at a U.S. slaughter plant.Microvesicle Involvement in Shiga Toxin-Associated Infection.Is eculizumab efficacious in Shigatoxin-associated hemolytic uremic syndrome? A narrative review of current evidence.Public Health Research Resulting from One of the World's Largest Outbreaks Caused by Entero-Hemorrhagic Escherichia coli in Germany 2011: A Review.Diffusion-weighted imaging of the kidneys in haemolytic uraemic syndrome.Thrombotic Microangiopathy and the Kidney.Molecular Mechanisms Governing "Hair-Trigger" Induction of Shiga Toxin-Encoding Prophages.Enterohemorrhagic colitis with disseminated intravascular coagulation.Management of hemolytic uremic syndromeShort- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood
P2860
Q27026538-621B355F-5057-4C5D-B8A5-F89AD5ABFF2CQ28083347-A8CB1CC4-8267-47AA-94A9-1DAC46287ED2Q30244707-8666226C-9E88-4CD6-9577-F84AAED366D5Q33403361-3B8BAFDA-6D34-41B4-A3C8-7E6004F6F78EQ33404149-6385B817-D112-4362-A07C-EFE9517BEDF5Q33404151-1F3C804F-009E-4FD0-A9F6-E6928EDA6335Q33404545-BA31D692-782E-4501-A702-58453A92ADE0Q33406669-3B533491-76DA-4DB8-A857-3682A94FFEFAQ33407564-206C0B37-6E57-4E4F-B840-219FD5C9D366Q33409030-F4401536-1D16-4015-ADFE-DF391D78EB02Q33411533-D7A66FFF-C514-457D-9BF2-FCDCD36A8D3AQ33411810-6528485C-166C-47CE-A872-3669C863C203Q33413591-7A2C7DD6-0D0E-4D73-8066-B992E8C78D2CQ33414177-316B604D-63BA-480C-A82B-80B78C2136DAQ33414804-1F3F2F97-0D63-4BD0-BDC1-37314B48BF8DQ33416244-7162F6A0-54E1-4958-A8A0-53C83848405BQ33424483-A5954941-7AC6-49DA-BBB3-96A3525CBE56Q33427620-A492D04E-E4CB-48AF-A08B-5088FB4A64B5Q33436459-2143F8D0-9027-4EB0-81F3-E632A6C1F8BDQ33442019-E46C8FB0-E31C-409A-8E79-27A49E42B1A4Q34298167-47CCF926-1E4D-429A-B119-A66DA191B9AAQ34787398-5A45905A-7EA6-4699-B6F1-ACAC6DB96162Q36563022-90C4EFBF-3349-492D-B321-C909A3E480A0Q38082735-056AA945-407E-4C3D-BBD4-621C788AA83BQ38232593-93649841-677D-44AB-B4AD-7A1A3BD6253DQ38886279-E5B45D8E-32E2-4111-9225-C6DD16E68BE4Q39758002-56F64FBF-9165-40CC-B970-D0FE8BAD6CBAQ40612027-4A471428-B570-42B2-84E9-24C52EAAF891Q42086661-689CF2B1-4779-453F-9098-49F23FAA4D1CQ44869577-6090CB68-0642-45F2-B49A-1EE85BA20B14Q47127903-B8FCCF19-8713-4741-94F9-B2741EB74E43Q47232330-A878C1F3-7EF8-4A62-A3FC-8FEAC5F9BEA5Q47295032-733023A0-BE87-4009-A7AE-CA710547EC71Q47764775-8D8B61FA-0C51-4BC8-8EF9-AFC0E525EF72Q50085453-CCE934F0-C9B7-470C-8AF5-FFCC2B446CF1Q55142308-87E2C24C-F16C-477F-A46A-FF6260379C28Q55278738-F4B9D018-0773-4A9A-9DE2-B216EEE605ECQ57161996-E6845282-BEA4-48E9-B52C-1904BB3A5E20Q58797348-E64AD589-C8C6-4E29-85AE-4A8A2704478C
P2860
An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
An outbreak of Shiga toxin-pro ...... hort-term outcome in children.
@ast
An outbreak of Shiga toxin-pro ...... hort-term outcome in children.
@en
type
label
An outbreak of Shiga toxin-pro ...... hort-term outcome in children.
@ast
An outbreak of Shiga toxin-pro ...... hort-term outcome in children.
@en
prefLabel
An outbreak of Shiga toxin-pro ...... hort-term outcome in children.
@ast
An outbreak of Shiga toxin-pro ...... hort-term outcome in children.
@en
P2093
P2860
P356
P1476
An outbreak of Shiga toxin-pro ...... hort-term outcome in children.
@en
P2093
Bernd Hoppe
Brigitta Kranz
Christoph Härtel
Dieter Haffner
Dominik Müller
Georg Hillebrand
Hagen Staude
Jens König
Johanna Lemke
P2860
P304
P356
10.1093/CID/CIS531
P407
P577
2012-06-05T00:00:00Z